What's breaking now, across thousands of outlets.
A combination of the shot and the immunotherapy Keytruda cut the risk of relapse or death by 42% in a landmark melanoma study that met Wall Street expectations but triggered a “sell-the-news reaction,” one analyst wrote.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Medicare negotiated drug prices for 15 drugs, including Ozempic, Wegovy and Trelegy Ellipta, take effect January 1, 2027, with cuts ranging from 38% to 85%
The Minister of Information and National Orientation, Mohammed Idris, has directed government information agencies to intensify public awareness about Ebola following the confirmation of a case in the…
The Federal Government has said that the Ebola patient in Abuja is responding well to treatment and showing signs of recovery.
Health officials are investigating where Nigeria's first patient, confirmed this week, was infected.
Vorzeitig bekannt gewordene Studiendaten zu einem Krebsimpfstoff setzen Moderna und Merck & Co. unter Druck. Die Moderna-Aktie verliert zeitweise 26 Prozent.
Moderna shares plunged as much as 25% after partial clinical trial data leaked for its personalized cancer vaccine developed with Merck, despite the full results showing promising outcomes for…
